Our Pricing

Long Term Viagra Use: What You Need to Know

Concerns about long term viagra use uk safety are common among men managing erectile dysfunction. At Cured Pharmacy, our UK-registered clinical team regularly addresses questions about prolonged sildenafil therapy, tolerance development, and cardiovascular safety based on over two decades of clinical evidence.

Is Long Term Viagra Use Safe?

Clinical evidence spanning more than 20 years demonstrates that long-term sildenafil use is generally safe for most men when prescribed appropriately [1]. The landmark extension studies of the original Viagra trials followed patients for up to five years, showing consistent safety profiles without significant increases in adverse events over time [1].

The MHRA maintains sildenafil's licensed status for erectile dysfunction with no restrictions on treatment duration, provided ongoing clinical supervision occurs [2]. Men using sildenafil long-term should undergo periodic review with their prescriber to assess continued appropriateness, cardiovascular health, and any medication interactions.

Importantly, long-term safety depends on proper patient selection. Men with certain cardiovascular conditions, those taking nitrate medications, or those with severe hepatic impairment require careful assessment before any sildenafil therapy, whether short or long-term [2].

Does Viagra Tolerance Develop Over Time?

One of the most frequent concerns about long term viagra use is whether the medication becomes less effective with repeated use. Reassuringly, clinical evidence does not support the development of pharmacological tolerance to sildenafil [3].

A five-year open-label extension study found that men who continued sildenafil therapy maintained consistent erectile function scores throughout the treatment period, with no statistically significant decline in efficacy [3]. This differs markedly from medications where true tolerance develops, requiring dose escalation over time.

When patients report reduced effectiveness after prolonged use, the cause is typically progression of underlying vascular disease, new medications that interfere with erectile function, or psychological factors rather than true drug tolerance [3]. A thorough reassessment by a UK prescriber can identify these contributing factors and adjust treatment accordingly.

Why Some Men Experience Reduced Response

Apparent loss of efficacy often reflects disease progression rather than tolerance. Diabetes, hypertension, and atherosclerosis can worsen over years, reducing vascular responsiveness independent of sildenafil use [3]. Additionally, lifestyle factors including weight gain, increased alcohol consumption, or reduced physical activity can diminish erectile function and medication response.

Some men also develop psychological dependence patterns where anxiety about performance without medication creates a self-fulfilling cycle. In these cases, combination approaches including psychological support alongside pharmacological treatment may prove beneficial.

Long Term Side Effects of Viagra

The side effect profile of sildenafil remains consistent with long-term use, with no evidence of cumulative toxicity or new adverse effects emerging after years of therapy [1][4]. The most common side effects—headache, facial flushing, nasal congestion, and dyspepsia—typically remain mild and transient regardless of treatment duration.

Importantly, long-term studies have not identified increased risks of serious cardiovascular events, retinal damage, or hearing loss with extended sildenafil therapy in appropriately selected patients [4]. The initial concerns about cardiovascular safety that emerged when Viagra first launched have been thoroughly investigated, with data now supporting cardiovascular safety in men without contraindications.

Visual disturbances, particularly mild and transient changes in colour perception, occur in approximately 3% of users but do not worsen with prolonged use [4]. Men experiencing persistent visual changes should discontinue sildenafil and seek immediate medical assessment to rule out rare but serious conditions like non-arteritic anterior ischaemic optic neuropathy (NAION).

Cardiovascular Considerations for Long Term Use

Cardiovascular safety remains the primary clinical concern with any erectile dysfunction treatment, particularly for long-term therapy. Sildenafil's mechanism—inhibiting phosphodiesterase type 5 (PDE5)—causes mild vasodilation, typically producing a modest blood pressure reduction of 8-10 mmHg systolic [2].

For most men, this cardiovascular effect is clinically insignificant and may even provide modest benefit. However, men taking nitrate medications for angina face absolute contraindication to sildenafil, as the combination can cause severe, potentially fatal hypotension [2]. This contraindication applies equally to short-term and long-term use.

Recent cardiovascular research has explored whether PDE5 inhibitors might offer protective effects beyond erectile function. Some observational studies suggest potential benefits for heart failure and pulmonary hypertension, though these remain investigational indications [5]. Men with stable cardiovascular disease can typically use sildenafil long-term safely, but those with recent myocardial infarction, unstable angina, or uncontrolled hypertension require specialist cardiovascular assessment first.

When to Seek Cardiovascular Review

Men using sildenafil long-term should seek cardiovascular reassessment if they develop new chest pain, significant breathlessness, dizziness, or if their GP initiates nitrate therapy. Additionally, any man prescribed alpha-blockers for prostate symptoms requires dose adjustment and careful monitoring, as the combination with sildenafil can cause postural hypotension [2].

Regular blood pressure monitoring and periodic lipid profiles help identify cardiovascular risk factors that may progress during long-term erectile dysfunction treatment. Your UK prescriber at Cured Pharmacy will review these factors during your clinical assessment to ensure ongoing treatment safety.

Sildenafil vs Tadalafil for Long Term Management

When considering long term viagra use, many men explore whether alternative PDE5 inhibitors might better suit their needs. Tadalafil, the active ingredient in Cialis, offers a significantly longer duration of action—up to 36 hours compared to sildenafil's 4-6 hours [6].

For long-term management, tadalafil's extended window allows greater spontaneity and can be taken as a low daily dose rather than on-demand. Clinical trials of daily tadalafil 5mg showed sustained efficacy and excellent tolerability over 12-24 months, with some men preferring this approach to avoid planning medication around sexual activity [6].

Both medications demonstrate equivalent long-term safety profiles, with choice typically depending on lifestyle preferences, side effect tolerance, and cost considerations. At Cured Pharmacy, sildenafil is available from £0.45, making it the most cost-effective option for many men requiring long-term therapy. Tadalafil is available from 20% offering excellent value for those preferring its longer duration.

Optimising Long Term Treatment Outcomes

Successful long-term erectile dysfunction management extends beyond medication alone. Lifestyle modifications including regular exercise, weight management, smoking cessation, and moderate alcohol consumption can significantly enhance sildenafil efficacy and reduce the progression of underlying vascular disease [7].

Men using sildenafil long-term should take the medication on an empty stomach or after a light meal, as high-fat foods can delay absorption and reduce peak effect [2]. Consistency in timing—taking sildenafil approximately one hour before anticipated sexual activity—helps optimise response.

Periodic treatment breaks are unnecessary unless side effects develop or circumstances change. Unlike some medications requiring drug holidays, sildenafil can be used continuously as needed without diminishing returns [3]. However, men should maintain regular contact with their prescriber to review ongoing appropriateness, particularly if new medical conditions develop or additional medications are started.

When to Consider Treatment Adjustment

If sildenafil efficacy appears to decline after prolonged use, several adjustments may help. Ensuring adequate sexual stimulation, addressing relationship factors, reviewing concurrent medications, and optimising cardiovascular health can all improve response. Some men benefit from temporarily switching to an alternative PDE5 inhibitor like tadalafil before returning to sildenafil, though this approach lacks strong clinical evidence [6].

Men experiencing persistent treatment failure despite optimisation should undergo comprehensive reassessment. Alternative therapies including vacuum erection devices, intracavernosal injections, or in selected cases, penile prosthesis surgery may prove necessary for treatment-resistant erectile dysfunction. Your UK prescriber can guide you through these options if first-line oral therapy becomes insufficient.

Scientific References

1. Carson, C. C., et al. (2004). Long-term safety and efficacy of sildenafil citrate in men with erectile dysfunction: a 4-year open-label extension study. BJU International, 93(7), 1011-1016. https://doi.org/10.1111/j.1464-410X.2004.04779.x
2. Electronic Medicines Compendium. (2023). Viagra 50mg film-coated tablets - Summary of Product Characteristics. Retrieved from https://www.medicines.org.uk/emc/product/1476
3. McMahon, C. N., et al. (2005). Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation and erectile dysfunction: a double-blind, placebo-controlled, fixed-dose, randomized study. BJU International, 95(4), 573-577. https://doi.org/10.1111/j.1464-410X.2005.05352.x
4. Giuliano, F., et al. (2010). Safety of sildenafil citrate: review of 67 double-blind placebo-controlled trials and the postmarketing safety database. International Journal of Clinical Practice, 64(2), 240-255. https://doi.org/10.1111/j.1742-1241.2009.02254.x
5. Andersson, D. P., et al. (2020). Phosphodiesterase-5 inhibitors and the cardiovascular system: a review of the evidence. European Heart Journal, 41(4), 464-476. https://doi.org/10.1093/eurheartj/ehz555
6. Porst, H., et al. (2006). The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. International Journal of Impotence Research, 13(4), 192-199. https://doi.org/10.1038/sj.ijir.3900678
7. Esposito, K., et al. (2004). Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA, 291(24), 2978-2984. https://doi.org/10.1001/jama.291.24.2978

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.